Wanbangde Pharmaceutical Holding Group Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 275.70% vs -77.32% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 158.14% vs -2,209.33% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "374.20",
          "val2": "99.60",
          "chgp": "275.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "138.80",
          "val2": "-91.00",
          "chgp": "252.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10.70",
          "val2": "3.50",
          "chgp": "205.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "7.60",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "100.70",
          "val2": "-173.20",
          "chgp": "158.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "370.90%",
          "val2": "-1,212.20%",
          "chgp": "158.31%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -22.49% vs -6.40% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -480.31% vs 71.86% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,112.90",
          "val2": "1,435.80",
          "chgp": "-22.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-23.10",
          "val2": "183.50",
          "chgp": "-112.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "40.10",
          "val2": "40.30",
          "chgp": "-0.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.50",
          "val2": "-16.20",
          "chgp": "127.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-171.90",
          "val2": "45.20",
          "chgp": "-480.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-125.20%",
          "val2": "53.30%",
          "chgp": "-17.85%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

374.20

99.60

275.70%

Operating Profit (PBDIT) excl Other Income

138.80

-91.00

252.53%

Interest

10.70

3.50

205.71%

Exceptional Items

0.00

7.60

-100.00%

Consolidate Net Profit

100.70

-173.20

158.14%

Operating Profit Margin (Excl OI)

370.90%

-1,212.20%

158.31%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 275.70% vs -77.32% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 158.14% vs -2,209.33% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,112.90

1,435.80

-22.49%

Operating Profit (PBDIT) excl Other Income

-23.10

183.50

-112.59%

Interest

40.10

40.30

-0.50%

Exceptional Items

4.50

-16.20

127.78%

Consolidate Net Profit

-171.90

45.20

-480.31%

Operating Profit Margin (Excl OI)

-125.20%

53.30%

-17.85%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -22.49% vs -6.40% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -480.31% vs 71.86% in Dec 2024

All Annual Results